BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Vercauteren K, Mesalam AA, Leroux-Roels G, Meuleman P. Impact of lipids and lipoproteins on hepatitis C virus infection and virus neutralization. World J Gastroenterol 2014; 20(43): 15975-15991 [PMID: 25473151 DOI: 10.3748/wjg.v20.i43.15975]
URL: https://www.wjgnet.com/1007-9327/full/v20/i43/15975.htm
Number Citing Articles
1
Ahmed Mesalam, Koen Vercauteren, Philip Meuleman. Mouse Systems to Model Hepatitis C Virus Treatment and Associated ResistanceViruses 2016; 8(6): 176 doi: 10.3390/v8060176
2
Jih-Kai Huang, Hsiang-Chun Lee. Emerging Evidence of Pathological Roles of Very-Low-Density Lipoprotein (VLDL)International Journal of Molecular Sciences 2022; 23(8): 4300 doi: 10.3390/ijms23084300
3
Lucy Rivett, Graeme Alexander. Is the conquest of Hepatitis C imminent?Expert Reviews in Molecular Medicine 2019; 21 doi: 10.1017/erm.2019.3
4
Alaa F. Bakr, Ping Shao, Mohamed A. Farag. Recent advances in glycyrrhizin metabolism, health benefits, clinical effects and drug delivery systems for efficacy improvement; a comprehensive reviewPhytomedicine 2022; 99: 153999 doi: 10.1016/j.phymed.2022.153999
5
E. I. Temnik, D. Y. Konstantinov, L. L. Popova. Characteristics of lipid metabolism disorders in patients with coronavirus infection-COVID-19 with chronic hepatitis CBulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH) 2023; 13(5): 109 doi: 10.20340/vmi-rvz.2023.5.CLIN.11
6
Alankrita Rani, Julia T. Stadler, Gunther Marsche. HDL-based therapeutics: A promising frontier in combating viral and bacterial infectionsPharmacology & Therapeutics 2024; 260: 108684 doi: 10.1016/j.pharmthera.2024.108684
7
Julien A. Menard, Myriam Cerezo-Magaña, Mattias Belting. Functional role of extracellular vesicles and lipoproteins in the tumour microenvironmentPhilosophical Transactions of the Royal Society B: Biological Sciences 2018; 373(1737): 20160480 doi: 10.1098/rstb.2016.0480
8
Makutiro Ghislain Masavuli, Danushka K. Wijesundara, Alexander Underwood, Dale Christiansen, Linda Earnest-Silveira, Rowena Bull, Joseph Torresi, Eric J. Gowans, Branka Grubor-Bauk. A Hepatitis C Virus DNA Vaccine Encoding a Secreted, Oligomerized Form of Envelope Proteins Is Highly Immunogenic and Elicits Neutralizing Antibodies in Vaccinated MiceFrontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.01145
9
Chelsea Pinkham, Aslaa Ahmed, Nicole Bracci, Aarthi Narayanan, Kylene Kehn-Hall. Host-based processes as therapeutic targets for Rift Valley fever virusAntiviral Research 2018; 160: 64 doi: 10.1016/j.antiviral.2018.10.004
10
Claudio M. Fader Kaiser, Patricia S. Romano, M. Cristina Vanrell, Cristian A. Pocognoni, Julieta Jacob, Benjamín Caruso, Laura R. Delgui. Biogenesis and Breakdown of Lipid Droplets in Pathological ConditionsFrontiers in Cell and Developmental Biology 2022; 9 doi: 10.3389/fcell.2021.826248
11
Waleed Ezzat Madboly, Magdi G. Shehata, Michael Sobhy M. Nashed, Ahmed M. Abu-Dief. Using power of calculated electrons to cut, analyze and exterminate the outer and the inner biological elements of hepatitis C virus without blood parameters disorders: In vitro study: low potential codified ions for hepatitis therapyAsian Journal of Applied Science and Engineering 2022; 11(1): 45 doi: 10.18034/ajase.v11i1.16
12
Gustavo Henrique De Puy e SOUZA, Luciana Diniz SILVA, Diego Alves VIEIRA, Gifone Aguiar ROCHA, Agnaldo Soares LIMA, Paula Vieira Teixeira VIDIGAL. HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND SYSTEMIC ARTERIAL HYPERTENSION ARE ASSOCIATED WITH HEPATIC NECROINFLAMMATORY ACTIVITY IN PATIENTS WITH CHRONIC HEPATITIS CArquivos de Gastroenterologia 2023; 60(3): 287 doi: 10.1590/s0004-2803.230302023-03
13
Germana Grassi, Giorgia Di Caprio, Gian Maria Fimia, Giuseppe Ippolito, Marco Tripodi, Tonino Alonzi. Hepatitis C virus relies on lipoproteins for its life cycleWorld Journal of Gastroenterology 2016; 22(6): 1953-1965 doi: 10.3748/wjg.v22.i6.1953
14
Hung-Yu Sun, Pin-Nan Cheng, Chiung-Ying Tseng, Wei-Jen Tsai, Yen-Cheng Chiu, Kung-Chia Young. Favouring modulation of circulating lipoproteins and lipid loading capacity by direct antiviral agents grazoprevir/elbasvir or ledipasvir/sofosbuvir treatment against chronic HCV infectionGut 2018; 67(7): 1342 doi: 10.1136/gutjnl-2017-313832
15
Ahmed Atef Mesalam. Hepatitis C Virus Vaccine Development: A Step ForwardThe Journal of Infectious Diseases 2021; 223(11): 2014 doi: 10.1093/infdis/jiaa644
16
Rania H. Khalifa, Dalia A. Labib, Mohamed A. Kamel, Rasha Mohamad Hosny Shahin, Dina M. Rasheed Bahgat, Nermine Magdi Riad, Engy El Khateeb, Amr M. El‐deeb, Marwa Hassan. Role of ApoB‐516C/T promoter gene polymorphism in the risk of Hepatitis C virus infection in Egyptian patients and in gender susceptibilityJournal of Medical Virology 2017; 89(9): 1584 doi: 10.1002/jmv.24815
17
Vladimir Alexei Morozov, Sylvie Lagaye. Hepatitis C virus: Morphogenesis, infection and therapyWorld Journal of Hepatology 2018; 10(2): 186-212 doi: 10.4254/wjh.v10.i2.186
18
Malgorzata Sidorkiewicz. Hepatitis C Virus Uses Host Lipids to Its Own AdvantageMetabolites 2021; 11(5): 273 doi: 10.3390/metabo11050273
19
Yoshio Aizawa, Nobuyoshi Seki, Tomohisa Nagano, Hiroshi Abe. Chronic hepatitis C virus infection and lipoprotein metabolismWorld Journal of Gastroenterology 2015; 21(36): 10299-10313 doi: 10.3748/wjg.v21.i36.10299